The association between C-reactive protein and delirium in 710 acute elderly hospital admissions

International Psychogeriatrics

Volumn 26, Issue 5, 2014, Pages 717-724

  Ritchie, C W ^a   Newman, T H ^a   Leurent, B ^b   Sampson, E L ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ST ANN S HOSPITAL   (United Kingdom)

Author keywords

biomarkers; C reactive protein; delirium; inflammation; neuropsychiatry; organic mental disorders; psychogeriatrics

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; DATA BASE; DELIRIUM; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PREVALENCE; RISK FACTOR; CLINICAL FEATURE; CORRELATION COEFFICIENT; DEMOGRAPHY; MUSCULOSKELETAL DISEASE; ACUTE DISEASE; BLOOD; COMPLICATION; CONFUSION; GERIATRIC ASSESSMENT; HOSPITALIZATION; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CONFUSION; DELIRIUM; FEMALE; GERIATRIC ASSESSMENT; HOSPITALIZATION; HUMANS; INFECTION; LONDON; MALE; MUSCULOSKELETAL DISEASES; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84897510372     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610213002433     Document Type: Article

References (46)

1. Adamis, D. et al. (2009). Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients. Age and Ageing, 38, 326-332; discussion 251. doi:10.1093/ageing/afp014.
2. Aldemir, M., Ozen, S., Kara, I. H., Sir, A. and Bac, B. (2001). Predisposing factors for delirium in the surgical intensive care unit. Critical Care (London, England), 5, 265-270.
3. Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B. and Tenner, A. J. (2008). The complement cascade: yin-yang in neuroinflammation-neuro- protection and degeneration. Journal of Neurochemistry, 107, 1169-1187. doi:10.1111/j.1471-4159.2008.05668.x.
4. Ballou, S. P. and Lozanski, G. (1992). Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine, 4, 361-368.
5. Black, S., Kushner, I. and Samols, D. (2004). C-reactive protein. The Journal of Biological Chemistry, 279, 48487-48490. doi:10.1074/jbc.R400025200.
6. Bruce, A. J., Ritchie, C. W., Blizard, R., Lai, R. and Raven, P. (2007). The incidence of delirium associated with orthopedic surgery: a meta-analytic review. International Psychogeriatrics, 19, 197-214. doi:10.1017/ S104161020600425X.
7. Cerejeira, J., Firmino, H., Vaz-Serra, A. and Mukaetova-Ladinska, E. B. (2010). The neuroinflammatory hypothesis of delirium. Acta Neuropathologica, 119, 737-754. doi:10.1007/s00401-010-0674-1.
8. Cerejeira, J., Nogueira, V., Luis, P., Vaz-Serra, A. and Mukaetova-Ladinska, E. B. (2012). The cholinergic system and inflammation: common pathways in delirium pathophysiology. Journal of the American Geriatrics Society, 60, 669-675. doi:10.1111/j.1532-5415.2011.03883.x;10.1111/j.1532-5415. 2011.03883.x.
9. Charlson, M. E. (1987). Studies of prognosis: progress and pitfalls. Journal of General Internal Medicine, 2, 359-361.
10. Clyne, B. and Olshaker, J. S. (1999). The C-reactive protein. The Journal of Emergency Medicine, 17, 1019-1025.
11. Collins, N., Blanchard, M. R., Tookman, A. and Sampson, E. L. (2010). Detection of delirium in the acute hospital. Age and Ageing, 39, 131-135. doi:10.1093/ageing/afp201.
12. de Groot, V., Beckerman, H., Lankhorst, G. J. and Bouter, L. M. (2003). How to measure comorbidity: a critical review of available methods. Journal of Clinical Epidemiology, 56, 221-229.
13. de Rooij, S. E., van Munster, B. C., Korevaar, J. C. and Levi, M. (2007). Cytokines and acute phase response in delirium. Journal of Psychosomatic Research, 62, 521-525. doi:10.1016/j.jpsychores.2006.11.013.
14. Elie, M., Cole, M. G., Primeau, F. J. and Bellavance, F. (1998). Delirium risk factors in elderly hospitalized patients. Journal of General Internal Medicine, 13, 204-212.
15. Hopstaken, R. M., Muris, J. W., Knottnerus, J. A., Kester, A. D., Rinkens, P. E. and Dinant, G. J. (2003). Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. The British Journal of General Practice, 53, 358-364.
16. Hshieh, T. T., Fong, T. G., Marcantonio, E. R. and Inouye, S. K. (2008). Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 63, 764-772.
17. Inouye, S. K., van Dyck, C. H., Alessi, C. A., Balkin, S., Siegal, A. P. and Horwitz, R. I. (1990). Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Annals of Internal Medicine, 113, 941-948.
18. Juma, W. M., Lira, A., Marzuk, A., Marzuk, Z., Hakim, A. M. and Thompson, C. S. (2011). C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion. Brain Research, 1414, 85-93. doi:10.1016/j.brainres. 2011.07.047.
19. Knaus, W. A., Draper, E. A., Wagner, D. P. and Zimmerman, J. E. (1985). APACHE II: a severity of disease classification system. Critical Care Medicine, 13, 818-829.
20. Kuhlmann, C. R. et al. (2009). Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke, 40, 1458-1466. doi:10.1161/STROKEAHA. 108.535930.
21. Kushner, I., Jiang, S. L., Zhang, D., Lozanski, G. and Samols, D. (1995). Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1?. Annals of the New York Academy of Sciences, 762, 102-107.
22. Lee, H. et al. (2007). Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells (Dayton, Ohio), 25, 1931-1939. doi:10.1634/stemcells.2007-0097.
23. Macdonald, A., Adamis, D., Treloar, A. and Martin, F. (2007). C-reactive protein levels predict the incidence of delirium and recovery from it. Age and Ageing, 36, 222-225. doi:10.1093/ageing/afl121.
24. Mold, C., Gewurz, H. and Du Clos, T. W. (1999). Regulation of complement activation by C-reactive protein. Immunopharmacology, 42, 23-30.
25. Pepys, M. B. and Hirschfield, G. M. (2003). C-reactive protein: a critical update. Journal of Clinical Investigation, 111, 1805-1812. doi:10.1172/JCI18921.
26. Perry, V. H. (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain, Behavior, and Immunity, 18, 407-413. doi:10.1016/j.bbi.2004.01.004.
27. Pisani, M. A., Murphy, T. E., Van Ness, P. H., Araujo, K. L. and Inouye, S. K. (2007). Characteristics associated with delirium in older patients in a medical intensive care unit. Archives of Internal Medicine, 167, 1629-1634. doi:10.1001/archinte.167.15.1629.
28. Quan, N. and Banks, W. A. (2007). Brain-immune communication pathways. Brain, Behavior, and Immunity, 21, 727-735. doi:10.1016/j.bbi.2007.05.005.
29. Rudolph, J. L., Salow, M. J., Angelini, M. C. and McGlinchey, R. E. (2008). The anticholinergic risk scale and anticholinergic adverse effects in older persons. Archives of Internal Medicine, 168, 508-513. doi:10.1001/ archinternmed.2007.106; 10.1001/archinternmed.2007.106.
30. Salmon, J. E. and Pricop, L. (2001). Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis and Rheumatism, 44, 739-750.
31. Sampson, E. L., Blanchard, M. R., Jones, L., Tookman, A. and King, M. (2009). Dementia in the acute hospital: prospective cohort study of prevalence and mortality. The British Journal of Psychiatry, 195, 61-66. doi:10.1192/bjp.bp.108.055335.
32. Sanders, R. D. (2011). Hypothesis for the pathophysiology of delirium: role of baseline brain network connectivity and changes in inhibitory tone. Medical Hypotheses, 77, 140-143. doi:10.1016/j.mehy.2011.03.048.
33. Sanderson, C. and Dixon, J. (2000). Conditions for which onset or hospital admission is potentially preventable by timely and effective ambulatory care. Journal of Health Services Research & Policy, 5, 222-230.
34. Seo, W. K. et al. (2012). C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 21, 181-186. doi:10.1016/j.jstrokecerebrovasdis.2010. 06.002.
35. Siddiqi, N., House, A. O. and Holmes, J. D. (2006). Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age and Ageing, 35, 350-364. doi:10.1093/ageing/afl005.
36. Speciale, S., Bellelli, G., Guerini, F. and Trabucchi, M. (2008). C-reactive protein levels and delirium in a rehabilitation ward. Age and Ageing, 37, 122-123. doi:10.1093/ageing/afm176.
37. Thomas, C., Kreisel, S. H., Oster, P., Driessen, M., Arolt, V. and Inouye, S. K. (2012). Diagnosing delirium in older hospitalized adults with dementia: adapting the Confusion Assessment Method to International Classification of Diseases, Tenth Revision, Diagnostic Criteria. Journal of the American Geriatrics Society, 60, 1471-1477. doi:10.1111/j.1532-5415.2012.04066. x; 10.1111/j.1532-5415.2012.04066.x.
38. Tilvis, R. S., Kahonen-Vare, M. H., Jolkkonen, J., Valvanne, J., Pitkala, K. H. and Strandberg, T. E. (2004). Predictors of cognitive decline and mortality of aged people over a 10-year period. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 59, 268-274.
39. Uchikado, H. et al. (2004). Activation of vascular endothelial cells and perivascular cells by systemic inflammation-an immunohistochemical study of postmortem human brain tissues. Acta Neuropathologica, 107, 341-351. doi:10.1007/s00401-003-0815-x.
40. van Gool, W. A., van de Beek, D. and Eikelenboom, P. (2010). Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet, 375, 773-775. doi:10.1016/S0140-6736(09)61158-2.
41. Volanakis, J. E. (1982). Complement activation by C-reactive protein complexes. Annals of the New York Academy of Sciences, 389, 235-250.
42. Wei, L. A., Fearing, M. A., Sternberg, E. J. and Inouye, S. K. (2008). The Confusion Assessment Method: a systematic review of current usage. Journal of the American Geriatrics Society, 56, 823-830. doi:10.1111/j.1532-5415.2008. 01674.x.
43. White, S., Eeles, E., O'Mahony, S. and Bayer, A. (2008). Delirium and C-reactive protein. Age and Ageing, 37, 123-124; author reply 124. doi:10.1093/ageing/afm178.
44. Willard, L. B., Hauss-Wegrzyniak, B. and Wenk, G. L. (1999). Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience, 88, 193-200.
45. Wright, R. J. and Frier, B. M. (2008). Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes/Metabolism Research and Reviews, 24, 353-363. doi:10.1002/dmrr.865.
46. Yeh, K. H. et al. (2012). Comparison of acute versus convalescent stage high-sensitivity C-reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin. Journal of Translational Medicine, 10, 6. doi:10.1186/1479-5876-10-6.